It is widely reported about the meningitis outbreak that has occurred in certain states of America. Contaminated Methylprednisolone Acetate injections led to fungal meningitis in over 500 patients. The contamination turned out to be tragic for 39 individuals: they died. The majority of deaths took place in Tennessee.
It was said that contaminated steroid injections had been manufactured by the New England Compounding Center (NECC) that is based in Massachusetts. The FDA tested the pharmacy in order to determine what caused contamination and see the situation at the NECC. It was affirmed by the FDA that the contaminated steroid injections were really manufactured by this company.
According to the Associated Press, the FDA reported that it was evident that preparing of preparations was unsterile at the NECC. The FDA noticed that leaking water and uncontrolled temperature were just several problems at the compounding center. The equipment used for preparing of solution for injections was unsterile.
Furthermore, the FDA stated that there were certain other contaminants. Several bacterial contaminants were found at the compounding center. Although these contaminants were not real pathogens, they were able to result in infection too. These bacterial contaminants were found in such preparations, as Betamethasone and Triamcinolone. There were not any situations reported about contamination resulted from administration of these medications. But it was claimed that these products could also produce contamination. Although the bacterial contaminants presented anywhere in the environment, they had not to be in medicines. This fact pointed at unsterile conditions at the NECC and affirmed that the Methylprednisolone Acetate injections turned out to be contaminated with fungal meningitis because they were manufactured in inappropriate conditions.
The situation made it clear that new rules on compounding pharmacies should be implemented. Contamination should be avoided. Otherwise, public health is in danger in the USA.